Viktor Reshetnikov

Nikolaus Fiebiger Str. 10
Erlangen, BY 91058, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Current Trends in Clinical Trials of Prodrugs.

Current Trends in Clinical Trials of Prodrugs.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 16, 2025

A concept of dual-responsive prodrugs based on oligomerization-controlled reactivity of ester groups: an improvement of cancer cells versus neutrophils selectivity of camptothecin.

A concept of dual-responsive prodrugs based on oligomerization-controlled reactivity of ester groups: an improvement of cancer cells versus neutrophils selectivity of camptothecin.

Journal: RSC medicinal chemistry

Published: November 02, 2023

Cyanine- and Rhodamine-Derived Alkynes for the Selective Targeting of Cancerous Mitochondria through Radical Thiol-Yne Coupling in Live Cells.

Cyanine- and Rhodamine-Derived Alkynes for the Selective Targeting of Cancerous Mitochondria through Radical Thiol-Yne Coupling in Live Cells.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: April 28, 2023

Intracellular Amplifiers of Reactive Oxygen Species Affecting Mitochondria as Radiosensitizers.

Intracellular Amplifiers of Reactive Oxygen Species Affecting Mitochondria as Radiosensitizers.

Journal: Cancers

Published: December 15, 2021

N-Alkylaminoferrocene-Based Prodrugs Targeting Mitochondria of Cancer Cells.

N-Alkylaminoferrocene-Based Prodrugs Targeting Mitochondria of Cancer Cells.

Journal: Molecules (Basel, Switzerland)

Published: April 30, 2020

Identification of Boronic Acid Derivatives as an Active Form of N-Alkylaminoferrocene-Based Anticancer Prodrugs and Their Radiolabeling with 18F.

Identification of Boronic Acid Derivatives as an Active Form of N-Alkylaminoferrocene-Based Anticancer Prodrugs and Their Radiolabeling with 18F.

Journal: Bioconjugate chemistry

Published: February 16, 2019

Radiosynthesis of an 18 F-fluoroglycosylated aminoferrocene for in-vivo imaging of reactive oxygen species activity by PET.

Radiosynthesis of an 18 F-fluoroglycosylated aminoferrocene for in-vivo imaging of reactive oxygen species activity by PET.

Journal: Journal of labelled compounds & radiopharmaceuticals

Published: June 26, 2018

ROS-Responsive N-Alkylaminoferrocenes for Cancer-Cell-Specific Targeting of Mitochondria.

ROS-Responsive N-Alkylaminoferrocenes for Cancer-Cell-Specific Targeting of Mitochondria.

Journal: Angewandte Chemie (International ed. in English)

Published: May 23, 2018

A cancer specific oxaliplatin-releasing Pt(iv)-prodrug.

A cancer specific oxaliplatin-releasing Pt(iv)-prodrug.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: May 01, 2018

Chemical Tools for Targeted Amplification of Reactive Oxygen Species in Neutrophils.

Chemical Tools for Targeted Amplification of Reactive Oxygen Species in Neutrophils.

Journal: Frontiers in immunology

Published: April 18, 2018

Cancer-Specific, Intracellular, Reductive Activation of Anticancer PtIV Prodrugs.

Cancer-Specific, Intracellular, Reductive Activation of Anticancer PtIV Prodrugs.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: March 16, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026